On May 24, 2023 Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage gene editing company developing ARCUS-based in vivo gene editing and ex vivo allogeneic CAR T therapies, reported that the Company will participate in the Stifel Genetic Medicines Day taking place May 30, 2023 (Press release, Precision Biosciences, MAY 24, 2023, View Source [SID1234632002]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details for the virtual fireside chat are as follows:
Date: Tuesday, May 30, 2023
Time: 2:25 PM ET

The fireside chat will be available via a live webcast accessible on Precision’s website in the Investors section under Events & Presentations on May 30, 2023: View Source An archived replay will be available for approximately 30 days following the event.